Updates in Urologic Oncology

When it comes to defeating cancer, Fox Chase Cancer Center never rests on its laurels. Every day, Fox Chase faculty, fellows, and residents discover innovative, life-enhancing cancer therapies and deliver care in the most compassionate way.


International Kidney Cancer Collaboration with Leadership from Philadelphia

Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, ...

Beyond the Routine – Adapt or Not?

Challenges and Dilemmas in Adaptive Radiation Treatment Planning
Eric M. Horwitz, MD, FABS, FASTRO

Eric M. Horwitz, MD, FABS, FASTRO

Chair and Professor, Department of Radiation Oncology
Fox Chase Cancer Center & Lewis Katz School of Medicine at Temple University

Connecting Across Continents: From Philadelphia to Kigali

When Samuel Ivan, MD chose a Reconstructive and Prosthetic Urology Fellowship at Fox Chase, his goal was to train with Fellowship Director Jay Simhan MD, FACS, Chair of the Department of Urology at Temple University Hospital and the Lewis ...

Fox Chase – Temple Urologic Institute’s Jennifer Kelly Becomes First Temple Health Nurse to Earn Certification from Society of Urologic Nurses & Associates

Jennifer Kelly, BSN, RN, CURN, a nurse with the Fox Chase-Temple Urologic Institute, has become the first nurse in the Temple Health system to earn certification from the Society of Urologic Nurses & Associates (SUNA).

Our Motto: Professional, Personable, and Proactive

“As the front line of a patient’s journey, our front desk and surgery scheduling teams play a crucial role in shaping each patient’s first impression of the Fox Chase Cancer Center – Temple Health brand within our urology outpatient clinics. ...

Fox Chase Cancer Center and Temple Researchers Highlight Need for Molecular Testing in Diagnosing Two Types of Kidney Cancer

Genetic testing may be the most effective way for researchers to distinguish between a rare form of kidney cancer and another that is more common, potentially preventing misdiagnoses, according to a recent study by researchers at Fox Chase ...